Delivery Order SPE2DB24D2100-SPE2DB25FBEKW
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,276.61 on August 8, 2025, for the supply of Pediarix 0.5 ML syringes. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 11, 2025, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's broader contractual...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Pediarix 0.5 ML syringes with a firm fixed price ceiling value of $3,649.76 and an ultimate completion date of November 4, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December...
- The Defense Logistics Agency awarded a $5,790.31 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Pediarix 0.5 mL syringes, with an ultimate completion date of May 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Pediarix 0.5 ML syringes valued at $2,753.62 with a completion date of September 2, 2025. This is a firm fixed-price, non-set-aside delivery order to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $5,344.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This firm fixed price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a pediatric vaccine delivery under the agency's medical supply chain operations. The award utilizes no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 mL syringes valued at $22,056.50 with an ultimate completion date of August 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains an extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Pediarix 0.5 ML syringes valued at $8,506.00 with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,732.92, for the supply of Pediarix 0.5 ML syringes effective September 11, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine product. This competitively awarded, non-set-aside contract is valued at $6,988.75 with a firm fixed price and an ultimate completion date of September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBEKWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Pediarix 0.5 ML syringes valued at $1,229.72 with a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The award was made through competitive procurement with no set-aside designation, and performance is scheduled for completion by May 30, 2025, at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This contract reflects the company's role in supplying essential pharmaceutical products, including vaccines and medical supplies, to the Defense Health Agency and other federal healthcare entities. The DLA Pharmaceutical Prime Vendor program under which this delivery order falls is designed to provide comprehensive global pharmaceutical support to military healthcare programs, with the agency planning to establish next-generation contracts across multiple regions and contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/29/25 |